ARMRA Colostrum Lawsuit Alleges Pricey Supplements Are Neither Legit Nor ‘Research-Backed’ [DISMISSED]

New to ClassAction.org? Read our Newswire Disclaimer

A proposed class action lawsuit alleges ARMRA Colostrum supplements are falsely advertised amid a “fraudulent scheme” to mislead consumers to believe the pricey products are scientifically and pharmaceutically legitimate.

Get class action lawsuit news sent to your inbox – sign up for ClassAction.org’s free weekly newsletter here.

The 28-page ARMRA Colostrum lawsuit says that the supplements, touted by defendant Rahal Biosciences as “research-backed” and able to bolster immunity, metabolism, gut health and sleep, among other purported health benefits, were never tested in any peer-reviewed clinical trial and are backed only by “deeply flawed” studies. Moreover, the advertising and labeling of the ARMRA Colostrum supplements include several disease claims without requisite disclaimers next to the statements, as mandated by the United States Food and Drug Administration (FDA), the case states.

The false advertising case summarizes that the ARMRA Colostrum supplements at issue, in light of the foregoing, are considered unapproved and misbranded “new drugs” under federal law and thus illegal to sell and worthless.

“As a result of its deceptive conduct, Defendant is, and continues to be, unjustly enriched at the expense of its customers,” the suit charges.

Colostrum is a nutrient-rich pre-milk produced by all female mammals immediately after giving birth and is packed with immune-boosting ingredients essential to newborns, the filing explains. The case says Rahal Biosciences is among a few companies that have attempted to capitalize on increasing consumer interest in cow-based colostrum dietary supplements for adults, including by advertising the “liquid gold” products as “physician-developed,” “research-backed,” and able to confer immune system and gut-health benefits while improving sleep and hair growth.

The class action lawsuit, citing a recent Truth In Advertising article, alleges Rahal Biosciences’ claims that its ARMRA Colostrum supplements are “research-backed” are a hoax, as the company relies on four ostensible studies that “merely analyze the potential benefits of colostrum based on an overview of other studies.”

“As such, the conclusions drawn by Defendant’s ‘studies’ are based on inferences and conjecture rather than reliable scientific evidence,” the filing contests.

In fact, the case goes on, one Rahal Biosciences study, which examined nine other studies on the efficacy of bovine colostrum on leaky guts, concluded that more research is needed on the matter.

Even the conclusions in Rahal Biosciences’ own studies suggest that more research is needed to confirm any of the health benefits promised by the ARMRA supplements, the lawsuit adds.

“It is thus unsurprising that Plaintiff did not experience any of the so-called ‘Research-Based’ benefits falsely advertised in the Products,” the case scathes.

Compounding matters, the suit says, is that the ARMRA Colostrum supplements are advertised with impermissible disease claims that wrongfully suggest the products “mitigate, treat, cure, or prevent diseases.” The Federal Food, Drug and Cosmetic Act strictly regulates any dietary supplement touted as intended for use in the diagnosis, cure, mitigation, treatment or prevention of a disease, the lawsuit emphasizes.

“Here, Defendant’s Products are ‘drugs’ rather than dietary supplements for multiple reasons, including the fact that they are marketed to induce ‘hair growth.’ FDA regulations expressly establish that hair growth products are ‘new drugs.’”

The suit further claims that Rahal Biosciences fails to prominentaly display a mandatory disclaimer that its health claims have not been evaluated by the FDA and that its products are not intended to diagnose, cure or prevent disease.

The lawsuit looks to cover all persons in the U.S. who, during the applicable statute of limitations period, bought Rahal Biosciences’ ARMRA Colostrum supplements primarily for personal, family or household use, and not for resale.

Are you owed unclaimed settlement money? Check out our class action rebates page full of open class action settlements.